Jackson Creek Investment Advisors LLC Innoviva, Inc. Transaction History

Jackson Creek Investment Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$11.39 - $13.72 $826,857 - $996,003	72,595 New	72,595 $924,000
Q4 2022 Feb 03, 2023	BUY	$11.8 - $13.78 $744,945 - $869,945	63,131 New	63,131 $836,000
Q1 2021 May 27, 2021	SELL	$11.06 - $12.87 $684,945 - $797,039	-61,930 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$9.33 - $12.48 $998 - $1,335	-107 Reduced 0.17%	61,930 $767,000
Q3 2020 Nov 09, 2020	BUY	$10.33 - $14.49 $640,842 - $898,916	62,037 New	62,037 $648,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.